Emotional Group for Healthy Subjects (HS)

Phase-Based Progress Estimates
Healthy Subjects (HS)
Rational Appeal - Behavioral
18 - 65
All Sexes
What conditions do you have?

Study Summary

The current study seeks to understand factors that influence college students' likelihood of participating the National Marrow Donor Program (NMDP)/Be the Match for bone marrow and stem cell donations. The secondary aim is to compare emotional and rational approaches to encouraging participation in the registry and how these approaches may impact intentions to participate in the NMDP.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Healthy Subjects (HS)

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Baseline

Intention to register
Psychosocial and Demographic Correlates of intentions to register

Trial Safety

Safety Progress

1 of 3

Other trials for Healthy Subjects (HS)

Trial Design

2 Treatment Groups

Emotional Group
1 of 2
Rational Group
1 of 2
Experimental Treatment

400 Total Participants · 2 Treatment Groups

Primary Treatment: Emotional Group · No Placebo Group · N/A

Emotional Group
Experimental Group · 1 Intervention: Emotional Appeal · Intervention Types: Behavioral
Rational Group
Experimental Group · 1 Intervention: Rational Appeal · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
369 Previous Clinical Trials
60,301 Total Patients Enrolled
6 Trials studying Healthy Subjects (HS)
146 Patients Enrolled for Healthy Subjects (HS)
Lauren C Daniel, Ph.D.Principal InvestigatorRutgers University

Eligibility Criteria

Age 18 - 65 · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are between the ages of 18-35.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 15th, 2021

Last Reviewed: October 8th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.